Shares of Elanco Animal Health (NASDAQ:ELAN) gapped up before the market opened on Friday after the company announced better than expected quarterly earnings. The stock had previously closed at $33.85, but opened at $32.96. Elanco Animal Health shares last traded at $33.05, with a volume of 43330 shares trading hands.
The company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.22 by $0.03. The firm had revenue of $731.10 million for the quarter, compared to analyst estimates of $743.40 million. The company’s revenue was down .7% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.33 EPS.
A number of analysts recently weighed in on the stock. Zacks Investment Research lowered shares of Elanco Animal Health from a “buy” rating to a “hold” rating in a research note on Tuesday, March 5th. UBS Group assumed coverage on shares of Elanco Animal Health in a research note on Wednesday, January 23rd. They set a “sell” rating and a $29.00 target price on the stock. Argus assumed coverage on shares of Elanco Animal Health in a research note on Tuesday, January 15th. They set a “buy” rating and a $37.00 target price on the stock. Bank of America upgraded shares of Elanco Animal Health from a “neutral” rating to a “buy” rating and set a $30.95 target price on the stock in a research note on Monday, March 18th. Finally, Morgan Stanley assumed coverage on shares of Elanco Animal Health in a research note on Wednesday, March 13th. They set an “equal weight” rating and a $34.00 target price on the stock. One analyst has rated the stock with a sell rating, six have assigned a hold rating and seven have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $33.47.
Institutional investors and hedge funds have recently made changes to their positions in the stock. Two Sigma Investments LP acquired a new stake in shares of Elanco Animal Health during the fourth quarter worth $3,333,000. TrimTabs Asset Management LLC acquired a new stake in Elanco Animal Health in the 1st quarter worth about $1,292,000. Chartwell Investment Partners LLC acquired a new stake in Elanco Animal Health in the 4th quarter worth about $251,000. LPL Financial LLC acquired a new stake in Elanco Animal Health in the 3rd quarter worth about $313,000. Finally, Kayne Anderson Rudnick Investment Management LLC boosted its stake in Elanco Animal Health by 8.2% in the 4th quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,813,388 shares of the company’s stock worth $57,176,000 after buying an additional 137,270 shares during the last quarter.
COPYRIGHT VIOLATION WARNING: “Elanco Animal Health (ELAN) Shares Gap Up on Strong Earnings” was reported by Baseball Daily News and is the property of of Baseball Daily News. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.baseballdailydigest.com/news/2019/05/10/elanco-animal-health-elan-shares-gap-up-on-strong-earnings.html.
Elanco Animal Health Company Profile (NASDAQ:ELAN)
There is no company description available for Elanco Animal Health Inc
Read More: Momentum Indicator: Relative Strength Index
Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.